BD Phoenix™ NMIC-306 449292Recalls & reported problems
Becton, Dickinson And Company · BD Phoenix™ NMIC-306 · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
Quick summary
This BD Phoenix NMIC-306 is an automated system that tests which drugs bacteria respond to. Its 143 reports mostly describe incorrect results, such as bacteria wrongly shown to resist or respond to a drug. There are no deaths and no injuries. 1 recall, still open, began in February 2024 over test panels found contaminated with other drugs before release. Reports fell to 16 in the last 12 months from 75 before.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 143
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 143 adverse event reports that list this exact device (DI 30382904492923), received between Aug 4, 2022 and May 27, 2026 — classified as 143 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (127 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Feb 29, 2024Open, Classified
Products were found to have confirmed drug cross contamination prior to release may lead to incorrect, inadequate, or absent antibiotic treatment or delay in results
Z-1398-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings127
- False Positive Result10
- False Negative Result6
Patient problems
- No Clinical Signs, Symptoms or Conditions143
Recent adverse event reports
The 25 most recent of 143 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 27, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT URINE ISOLATE (PSEUDOMONAS AERUGINOSA) HAD A HIGH MIC (FALSE RESISTANT) RESULT. THE USER STATED THAT THE P. AERUGINOSA WAS IDENTIFIED AS A CARBAPENEM-RESISTANT ENTEROBACTERALES (CRE). NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25301424 ↗MalfunctionMay 14, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE HAD A LOW MIC (FALSE SUSCEPTIBLE) RESULT FOR THE DRUG CEFTAZIDIME/AVIBACTAM BUT WHEN REPEATED THE RESULT WAS RESISTANT. THE USER STATED THE ISOLATE WAS PCR-POSITIVE RESULT FOR NEW DELHI METALLO-BETA-LACTAMASE (NDM). THE USER VERIFIED THE FINAL RESULT USING E- TEST. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25176793 ↗MalfunctionApr 1, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE HAD A HIGH MIC (FALSE RESISTANT) FOR THE DRUG ERTAPENEM BUT WHEN REPEATED THE RESULT WAS SENSITIVE. THE USER VERIFIED THE FINAL RESULT USING REPEAT TESTING. IT IS ALSO TO BE NOTED THAT THE UPSTREAM INSTRUMENT WAS FOUND TO BE CONTAMINATED. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24753003 ↗MalfunctionFeb 9, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306, THE DRUG AMOXICILLIN AND CLAVULANATE WAS REPORTED AS INTERMEDIATE WHEN THE USER EXPECTED THE RESULT TO BE RESISTANT FOR A PATIENT ISOLATE. IT IS TO BE NOTED THAT BASED ON CURRENT SOFTWARE RELEASE INTERMEDIATE IS THE EXPECTED RESULT. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24293017 ↗MalfunctionJan 20, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 THE USER NOTED CORRELATION FAILURES BETWEEN THE PANEL TYPES. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24120690 ↗MalfunctionDec 17, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT URINE ISOLATE (ESCHERICHIA COLI) HAD A SENSITIVE RESULT FOR THE DRUG CEFTAZIDIME/AVIBACTAM. CONVERSELY, THE USER NOTED THAT THE E-TEST RESULTS WERE RESISTANT FOR CEFTAZIDIME/AVIBACTAM DURING REPEAT TESTING. A REFERENCE LABORATORY WAS USED, AND THE CARBA-R PCR RESULT WAS SHOWING THE NEW DELHI METALLO-BETA-LACTAMASE (NDM) GENE PRESENT. THE USER STATED, "PATIENT WAS TREATED WITH INEFFECTIVE THERAPY (MEROPENEM) FOR THREE DAYS DUE TO FALSE SUSCEPTIBLE RESULT REPORTED."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23829341 ↗MalfunctionDec 17, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT BLOOD ISOLATE (ESCHERICHIA COLI) HAD A SENSITIVE RESULT FOR THE DRUG CEFTAZIDIME/AVIBACTAM. CONVERSELY, THE USER NOTED THAT THE E-TEST RESULTS WERE RESISTANT FOR CEFTAZIDIME/AVIBACTAM DURING REPEAT TESTING. A REFERENCE LABORATORY WAS USED, AND THE CARBA-R PCR RESULT WAS SHOWING THE NEW DELHI METALLO-BETA-LACTAMASE (NDM) GENE PRESENT. THE USER STATED, "PATIENT WAS TREATED WITH INEFFECTIVE THERAPY (CEFTAZIDIME/AVIBACTAM) FOR THREE DAYS DUE TO FALSE SUSCEPTIBLE RESULT REPORTED."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23829292 ↗MalfunctionDec 17, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT BLOOD ISOLATE (ESCHERICHIA COLI) HAD A RESISTANT RESULT FOR THE DRUGS CEFTAZIDIME/AVIBACTAM AND ERTAPENEM WHILE THE DRUG MEROPENEM WAS SENSITIVE. CONVERSELY, THE USER NOTED THAT THE E-TEST RESULTS WERE SENSITIVE FOR CEFTAZIDIME/AVIBACTAM AND ERTAPENEM DURING REPEAT TESTING. A REFERENCE LABORATORY WAS USED GIVING SENSITIVE RESULTS AND THE CARBA-R PCR RESULT SHOWING ALL CARBAPENEMASES "NOT DETECTED.". THE USER STATED, "THE PATIENT WAS TREATED WITH UNNECESSARY BROAD-SPECTRUM ANTIBIOTICS (CEFIDEROCOL AND ERAVACYCLINE) DUE TO FALSE RESISTANT CEFTAZIDIME AND AVIBACTAM RESULT REPORTED.".
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23828894 ↗MalfunctionDec 12, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE (CITROBACTER BRAAKII) HAD A HIGH MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (RESISTANT) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE. THE USER NOTED PERFORMING REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23794387 ↗MalfunctionDec 12, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE (ESCHERICHIA COLI) HAD A HIGH MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (RESISTANT) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE. THE USER NOTED PERFORMING REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23794382 ↗MalfunctionDec 10, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE (ESCHERICHIA COLI) HAD A HIGH MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (RESISTANT) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE AND MINOCYCLINE WAS SUSCEPTIBLE. IN ADDITION, THE EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) MARKER WAS NOT FLAGGED. THE USER NOTED PERFORMING REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23770366 ↗MalfunctionDec 10, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A REPEATED PATIENT ISOLATE (ESCHERICHIA COLI) HAD A LOW MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (SUSCEPTIBLE) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE, AND MINOCYCLINE WAS ALSO SUSCEPTIBLE. IN ADDITION, THE EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) MARKER WAS NOT FLAGGED. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23770351 ↗MalfunctionDec 10, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A REPEATED PATIENT ISOLATE (ESCHERICHIA COLI) HAD A LOW MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (SUSCEPTIBLE) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE, AND MINOCYCLINE WAS ALSO SUSCEPTIBLE. IN ADDITION, THE EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) MARKER WAS NOT FLAGGED. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23770350 ↗MalfunctionDec 10, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE (ESCHERICHIA COLI) HAD A HIGH MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (RESISTANT) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE AND MINOCYCLINE WAS INTERMEDIATE. IN ADDITION, THE EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) MARKER WAS FLAGGED. THE USER NOTED PERFORMING REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23770024 ↗MalfunctionDec 10, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE (ESCHERICHIA COLI) HAD A HIGH MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (RESISTANT) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE. THE USER NOTED PERFORMING REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23770022 ↗MalfunctionDec 10, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE (CITROBACTER BRAAKII) HAD A HIGH MIC FOR THE DRUG CEFTOLOZANE/TAZOBACTAM (RESISTANT) WHILE THE DRUG MEROPENEM WAS SUSCEPTIBLE. THE USER NOTED PERFORMING REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23770013 ↗MalfunctionOct 28, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 AN UNSPECIFIED NUMBER OF PATIENT ISOLATES HAD HIGH MICS (FALSE RESISTANT RESULT) FOR THE CARBAPENEM DRUG CLASS. THE USER NOTED NO LONGER USING THE DEVICE FOR CARBAPENEM MIC TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23404752 ↗MalfunctionOct 28, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE HAD HIGH MICS (FALSE RESISTANT RESULT) FOR THE DRUG ERTAPENEM. THE USER NOTED USING AN E-TEST STRIP FOR CONFIRMATORY TESTING GIVING A SUSCEPTIBLE RESULT. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23404742 ↗MalfunctionOct 28, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG ERTAPENEM. THE USER CONFIRMED THE RESULT USING E-TEST STRIP. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23404117 ↗MalfunctionOct 28, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG ERTAPENEM. THE USER CONFIRMED THE RESULT USING E-TEST STRIP. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23404109 ↗MalfunctionOct 28, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-306 A PATIENT ISOLATE HAD A HIGH MIC (FALSE RESISTANCE) FOR THE DRUG ERTAPENEM. THE USER CONFIRMED THE RESULT USING E-TEST STRIP. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23404104 ↗MalfunctionSep 3, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING BD PHOENIX PANEL NMIC-306, A SAMPLE GAVE DIFFERENT RESULTS WHEN RETESTED. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22953166 ↗MalfunctionSep 3, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING BD PHOENIX PANEL NMIC-306, A SAMPLE GAVE DIFFERENT RESULTS WHEN RETESTED. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22953165 ↗MalfunctionSep 2, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING BD PHOENIX PANEL NMIC-306, A PATIENT SAMPLE GAVE A FALSE RESISTANT RESULT. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22938667 ↗MalfunctionSep 2, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING BD PHOENIX PANEL NMIC-306, THERE WAS A FALSE RESISTANT RESULT FOR ERTAPENEM. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22938585 ↗
Other SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION devices
- BD Phoenix™ M50 Automated Microbiology System 443624Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION3 recalls417 reports
- BD Phoenix™ NMIC/ID-307 449289Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION529 reports
- BD Phoenix™ PMIC/ID-107 448607Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION2 recalls169 reports
- VITEK® 2 AST-GP67Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls83 reports
- BD Phoenix™ AST Broth 246003Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION182 reports
- VITEK® 2 AST-GP75Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls52 reports
- VITEK® 2 AST-GP78Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls41 reports
- VITEK® 2 AST-GN99Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page